Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The MHRA has issued warnings about the risks of obtaining unlicensed injectable peptides including GLP-1 receptor agonists from unregulated online sources, citing concerns about uncertain purity and potency, absence of validated stability data, risk of microbial contamination in preparations not manufactured under Good Manufacturing Practice (GMP) conditions, and the potential for mislabelling or adulteration
At JosephCareRX, patient safety is always our top priority
Bone and cardiovascular health GLP-1RAs influence bone metabolism by promoting bone formation and reducing resorption, potentially mitigating osteoporosis risk
Currently, only one study has been conducted on the safety of semaglutide in breastfeeding
